EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A Comparison between SARS-CoV-2 and Gram-Negative Bacteria-Induced Hyperinflammation and Sepsis

Klaus Brandenburg, Raquel Ferrer-Espada, Guillermo Martinez-de-Tejada iD, Christian Nehls iD, Satoshi Fukuoka, Karl Mauss, Günther Weindl iD, Patrick Garidel

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242015169 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Klaus Brandenburg und 7 weiteren Autor:innen. Beteiligte Einrichtung: Brandenburg Antiinfektiva, c/o Forschungszentrum Borstel, Leibniz-Lungenzentrum, Parkallee 10, 23845 Borstel, Germany. Hauptthemen laut MEDLINE: COVID-19, Sepsis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: C.N. Phospholipid Research Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepsis is a life-threatening condition caused by the body’s overwhelming response to an infection, such as pneumonia or urinary tract infection. It occurs when the immune system releases cytokines into the bloodstream, triggering widespread inflammation. If not treated, it can lead to organ failure and death. Unfortunately, sepsis has a high mortality rate, with studies reporting rates ranging from 20% to over 50%, depending on the severity and promptness of treatment. According to the World Health Organization (WHO), the annual death toll in the world is about 11 million. One of the main toxins responsible for inflammation induction are lipopolysaccharides (LPS, endotoxin) from Gram-negative bacteria, which rank among the most potent immunostimulants found in nature. Antibiotics are consistently prescribed as a part of anti-sepsis-therapy. However, antibiotic therapy (i) is increasingly ineffective due to resistance development and (ii) most antibiotics are unable to bind and neutralize LPS, a prerequisite to inhibit the interaction of endotoxin with its cellular receptor complex, namely Toll-like receptor 4 (TLR4)/MD-2, responsible for the intracellular cascade leading to pro-inflammatory cytokine secretion. The pandemic virus SARS-CoV-2 has infected hundreds of millions of humans worldwide since its emergence in 2019. The COVID-19 (Coronavirus disease-19) caused by this virus is associated with high lethality, particularly for elderly and immunocompromised people. As of August 2023, nearly 7 million deaths were reported worldwide due to this disease. According to some reported studies, upregulation of TLR4 and the subsequent inflammatory signaling detected in COVID-19 patients “mimics bacterial sepsis”. Furthermore, the immune response to SARS-CoV-2 was described by others as “mirror image of sepsis”. Similarly, the cytokine profile in sera from severe COVID-19 patients was very similar to those suffering from the acute respiratory distress syndrome (ARDS) and sepsis. Finally, the severe COVID-19 infection is frequently accompanied by bacterial co-infections, as well as by the presence of significant LPS concentrations. In the present review, we will analyze similarities and differences between COVID-19 and sepsis at the pathophysiological, epidemiological, and molecular levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SepsisHumansAgedSARS-CoV-2LipopolysaccharidesToll-Like Receptor 4EndotoxinsInflammationGram-Negative BacteriaCytokinesAnti-Bacterial Agents

Stichwörter der Autor:innen

ARDSAspidaseptCOVID-19 pandemicGram-negative bacteriaTLR4cytokineshyperinflammationlipopolysaccharidesepsis

Substanzen

LipopolysaccharidesToll-Like Receptor 4EndotoxinsCytokinesAnti-Bacterial Agents

Autor:innen und Institutionen

  • Brandenburg Antiinfektiva, c/o Forschungszentrum Borstel, Leibniz-Lungenzentrum, Parkallee 10, 23845 Borstel, Germany.
  • Department of Microbiology, University of Navarra, IdiSNA (Navarra Institute for Health Research), Irunlarrea 1, E-31008 Pamplona, Spain.
  • Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.
  • Forschungszentrum Borstel, FG Biophysik, Parkallee 10, 23845 Borstel, Germany.
  • National Institute of Advanced Industrial Science and Technology (AIST), Takamatsu 761-0395, Japan.
  • Sylter Klinik Karl Mauss, Dr.-Nicolas-Strasse 3, 25980 Westerland (Sylt), Germany.

ORCID-Profile: Guillermo Martinez-de-Tejada, Christian Nehls, Günther Weindl

Förderung

  • C.N. Phospholipid Research Center

Zitieren

APA

Brandenburg, K., Ferrer-Espada, R., Martinez-de-Tejada, G., Nehls, C., Fukuoka, S., Mauss, K., Weindl, G., & Garidel, P. (2023). A Comparison between SARS-CoV-2 and Gram-Negative Bacteria-Induced Hyperinflammation and Sepsis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242015169

Vancouver

Brandenburg K, Ferrer-Espada R, Martinez-de-Tejada G, Nehls C, Fukuoka S, Mauss K, et al. A Comparison between SARS-CoV-2 and Gram-Negative Bacteria-Induced Hyperinflammation and Sepsis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242015169

BibTeX
@article{Brandenburg2023,
  author = {Brandenburg, Klaus and Ferrer-Espada, Raquel and Martinez-de-Tejada, Guillermo and Nehls, Christian and Fukuoka, Satoshi and Mauss, Karl and Weindl, Günther and Garidel, Patrick},
  title = {A Comparison between SARS-CoV-2 and Gram-Negative Bacteria-Induced Hyperinflammation and Sepsis},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242015169}
}
Kostenlos starten →